Rheumatic Disease Clinics of North America

Article	Citations
Copyright	104
Osteoarthritis Treatment Guidelines from Six Professional Societies	82
Advancing Gastrointestinal Microbiota Research in Systemic Sclerosis	52
The Current Status of Exercise Applications as Medicine in Myositis Diseases on Behalf of MIHRA ICERS and MIHRA Clinical Trial Sites Network	37
Contents	34
Pediatric Rheumatology Comes of Age: Part II	33
Implementation Science in Pediatric Rheumatology: A Path to Health Equity	26
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis	21
Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	21
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children	21
Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases	21
Exploring the Mucosal Immune Response in Axial Spondyloarthritis Through Immunoglobulin A-Coated Microbiota	20
Copyright	19
Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease-Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy	19
COPA Syndrome from Diagnosis to Treatment	17
The Short and Long of COVID-19	16
Forthcoming Issues	16
Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica	16
Lessons Learned from the COVID-19 Pandemic in Rheumatology	15
Venous Thromboembolism in the Inflammatory Rheumatic Diseases	15
Taxonomy of Quality of Care Indicators	12
Newer Immunosuppressants for Rheumatologic Disease	12
Imaging Challenges and Developments in Large-vessel Vasculitis	12
Contributors	12
Copyright	11

The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events	11
Vaccinations in Patients with Rheumatic Disease	11
Contents	11
Multisystem Inflammatory Syndrome in Children and Kawasaki Disease	11
Pulmonary Hypertension Associated with Connective Tissue Disease	11
De novo Connective Tissue Disorders as Immune-related Adverse Events	11
Expanding the Treatment Team	10
It Takes Oysters to Generate Pearls	10
Primary Cardiac Involvement in Systemic Sclerosis	10
Copyright	9
Uveitis in Children and Adolescents	9
Cardiac MRI in Rheumatic Disease	8
Daniel J McCarty, MD: A Giant of Rheumatology	8
Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease	8
Charles L Christian	8
Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	8
Preventative Care in Scleroderma	7
Rheumatology Pearls for the Primary Care Physician	7
E Carwile LeRoy, MD	7
The Giants of Rheumatology at Johns Hopkins: Lawrence E Shulman, MD, PhD and Mary Betty Stevens, MD	7
Scleroderma: Best Approaches to Patient Care	7
Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019	7
Copyright	7
COVID-19 and Rheumatology	7
Assessing Patient-Reported Outcomes in Pediatric Rheumatic Diseases	7
Imaging of Pulmonary Manifestations of Connective Tissue Disease	7
Chronic Nonbacterial Osteomyelitis	7
Antinuclear Antibody Testing for the Diagnosis of Systemic Lupus Erythematosus	6
Contents	6
Contributors	6
Guideline Development and Implementation in Rheumatic Disease	6
Heart Failure in Rheumatic Disease	6
The Spectrum of Myocardial Disease in Idiopathic Inflammatory Myopathies	6
Contents	6
The Challenges of New Biologic Therapies in Pediatrics	6
Sustainable Health Care and Advocacy for Rheumatologists	6
Imaging of the Major Salivary Glands in Rheumatic Disease	6
A Guide to Contemporary Clinical Practice Guidelines	6
Beyond Coronary Artery Disease	5
Forthcoming Issues	5
Impacts of Storms, Precipitation, Drought, and Water Quality on Rheumatic Diseases	5
Genetic Defects in Early-Onset Inflammatory Bowel Disease	5
SARS-CoV-2 Infection and COVID-19 in Children	5
The Impact of Pediatric Rheumatic Diseases on Sexual Health, Family Planning, and Pregnancy	5
Contributors	5
The Role of Psychology in Pediatric Rheumatic Diseases	5
Environmental Triggers for Rheumatic Disease: From “Why Did I Get This?” to “How Can We Prevent This?”	5
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	5
Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis	5
Biomarkers in Childhood-Onset Systemic Lupus Erythematosus	5

Copyright	5
Cardiovascular Health in Pediatric Rheumatologic Diseases	5
Myositis	5
Environmental Risk Factors for Osteoarthritis: The Impact on Individuals with Knee Joint Injury	4
Ambient PM2.5 Exposure and the Incidence of Systemic Lupus Erythematosus	4
Expanding IPEX: Inborn Errors of Regulatory T Cells	4
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	4
Dual-Energy Computed Tomography Applications in Rheumatology	4
Patient Engagement in Pediatric Rheumatology Research	4
Role of Environment in Pediatric Rheumatic Diseases	4
Imaging in Inflammatory Bowel Disease	4
Health Care Utilization	4
Emerging and Expanding Infections due to Climate Change of Concern to Rheumatologists	4
Copyright	4
Updates in Systemic Sclerosis Treatment and Applicability to Pediatric Scleroderma	4
Management and Cure of Gouty Arthritis	4
CARRA	4
Molecular Biomarkers and Clinical Predictors of Psoriatic Arthritis	4
Contents	4
Treatment Guidelines in Pediatric Rheumatic Diseases	4
Treatment Guidelines in Gout	4
Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk	4
Pediatric Rheumatic Disease in Lower to Middle-Income Countries	3
Diagnostic Evaluation for Myositis and Their Pitfalls	3
Impact of Climate Change on Rheumatology Care	3
Instrumental Substance Use Among Youth with Rheumatic Disease—A Biopsychosocial Model	3
The GRADE Method	3
Contents	3
Mental Health in Pediatric Rheumatology	3
Interstitial Lung Disease	3
The Effects of Extreme Heat on Individuals with Rheumatic Conditions	3
Forthcoming Issues	3
Achieving Precision Medicine in Psoriatic Arthritis	3
Pediatric Rheumatology Comes of Age: Part I	3
Technology to Assess and Treat Pain in Pediatric Rheumatology	3
Pediatric Rheumatology Comes of Age: Part II	3
Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica	3
Forthcoming Issues	2
Forthcoming Issues	2
Training the Next Generation of Rheumatologists	2
COVID-19 in Pediatrics	2
Forthcoming Issues	2
Forthcoming Issues	2
Lifestyle, Hormonal, and Metabolic Environmental Risks for Rheumatoid Arthritis	2
Early Sexual Health and Reproductive Implications in Pediatric Rheumatic Diseases	2
Imaging in Juvenile Idiopathic Arthritis	2
Myositis in 2025: Defining Subtypes, Closing Gaps, and Shaping the Future	2
Perioperative Management of Rheumatic Disease and Therapies	2
Emerging Treatment Options for Inclusion Body Myositis	2
Patient-Reported Outcomes in Myositis	2
Outcome Measures in Pediatric Rheumatic Disease	1
Contributors	1
Systemic Diseases and Heart Block	1
Recent Updates in Juvenile Spondyloarthritis	1
Climate Change, Pollution, and Sustainability	1
Pesticides, Rheumatic Diseases, and Emerging Environmental Threats	1
The Current and Future of Biomarkers of Immune Related Adverse Events	1
Pediatric Rheumatology Comes of Age: Part I	1
Gerald P Rodnan	1
The Promises and Perils of Social Media for Pediatric Rheumatology	1
Nathan Zvaifler	1
Precision Medicine	1
Contributors	1
Juvenile Fibromyalgia	1
Axial Imaging in Spondyloarthritis	1
Cardiovascular Disease in Large Vessel Vasculitis	1
Treatment of Vascular Complications in Systemic Sclerosis	1
Treatment Guidelines in Vasculitis	1
Suspecting and Diagnosing the Patient with Spondyloarthritis and What to Expect from Therapy	1
Imaging in Rheumatology	1
Preface	1
J. Claude Bennett, MD	1
Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis	1
Forthcoming Issues	1
Targeting Environmental Risks to Prevent Rheumatic Disease	1
Impact of Stress and Eco-anxiety on Rheumatic Disease	1
Vasculitis	1
Forthcoming Issues	1
Foreword	1
Contributors	1

The Giants Of Rheumatology	1
Contributors	1
Copyright	0
The Meaningful Role of Patients, and Other Stakeholders in Clinical Practice Guideline Development	0
New Developments in Imaging in Crystalline Arthritis	0
Gut and Joint Microbiomes	0
John R. Ward, MD: Pioneer—Clinical Trials in Rheumatology	0
Copyright	0
Environmental Triggers of Hyperuricemia and Gout	0
Systemic Autoinflammatory Diseases	0
Environmental Risks for Systemic Sclerosis	0
Contents	0
Imaging Revolutions in Modern Rheumatology	0
The Future of Vasculitis	0
Mental Health Considerations in Chronic Disease	0
Juvenile Localized Scleroderma	0
Environmental Risks for Spondyloarthropathies	0
Copyright	0
The Emerging Telehealth Landscape in Pediatric Rheumatology	0
Lessons from Carl M. Pearson 1919 – 1981	0
Newer Immunosuppressants for Rheumatologic Disease	0
The Temporomandibular Joint in Juvenile Idiopathic Arthritis	0
Giant Cell Arteritis and Polymyalgia Rheumatica	0
Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis	0
Forthcoming Issues	0
Cardiovascular Complications of Chronic Rheumatic Diseases	0
Contributors	0
Managing Cardiovascular Risk in Patients with Rheumatic Disease	0
Forthcoming Issues	0
Preventative Care in Scleroderma	0
Myocardial Involvement in Systemic Autoimmune Rheumatic Diseases	0
Type I Interferonopathies	0
Immunotherapy Toxicity Management in Clinical Practice	0
Autoimmune Connective Tissue Diseases: Systemic Lupus Erythematosus and Rheumatoid Arthritis	0
Overview of Climate Change, Pollution, and Sustainability in the Rheumatic and Autoimmune Diseases	0
The Impact of Coronavirus Disease 2019 on Patients Living with Rheumatic Diseases	0
Central Nervous System Imaging in Rheumatic Diseases	0
Environmental Triggers for Rheumatic Diseases	0
Naomi Rothfield, MD, MACR	0
Using the Electronic Health Record to Enhance Care in Pediatric Rheumatology	0
Calcinosis in Adult and Juvenile Dermatomyositis	0
Contents	0
Combined Dermatology/Rheumatology Clinics for Management of Psoriatic Disease	0
Contributors	0
Pediatric Rheumatology Comes of Age: Part II	0
Forthcoming Issues	0
Axial Psoriatic Arthritis	0
Emerging Concepts in Immune Dysregulation	0
Management of Lung Manifestations in Idiopathic Inflammatory Myopathies	0
Rheumatoid Arthritis	0
Central Nervous System Vasculitis	0
Imaging of Rheumatic Diseases Affecting the Lower Limb	0
The Burden of Post-Acute Sequelae of Coronavirus Disease 2019 in Individuals with Rheumatic Diseases	0
How the American College of Rheumatology Develops Guidelines	0
Vasculitis and Pregnancy	0
Rheumatology Pearls for the Primary Care Physician	0
Gastrointestinal Tract Considerations: Part II	0
Updates in the Management of Immune-Mediated Necrotizing Myopathy	0
New and Emerging Rheumatic Diseases	0
Environmental Triggers for Rheumatic Diseases	0
Understanding the Spectrum of Immune Dysregulation Manifestations in Autoimmune Lymphoproliferative Syndrome and Autoimmune Lymphoproliferative Syndrome-like Disorders	0
Challenges in Developing Treatment Guidelines in Psoriatic Arthritis	0
Flares of Systemic Autoimmune Rheumatic Disease Following Coronavirus Disease 2019 Vaccination	0
Juvenile Idiopathic Arthritis Treatment Updates	0
Lessons on Telemedicine in Rheumatology	0
Pre-existing Autoimmune Diseases and Immune Checkpoint Inhibitors for Cancer Treatment: Considerations About Initiation, Flares, Immune-Related Adverse Events, and Cancer Progression	0
Interventions to Improve COVID-19 Vaccine Hesitancy	0
Scleroderma: Best Approaches to Patient Care	0
Edmund Lawrence Dubois (1923–1985)	0
Climate Change and the Exposome in Autoimmune Rheumatic Diseases	0
Isolated Aortitis	0
Contents	0
Approach to Systemic Sclerosis Patient Assessment	0
Environmental Risks for Inflammatory Myopathies	0
Patient Experience of Systemic Sclerosis–Related Calcinosis	0
Emerging Concepts in Immune Dysregulation	0
Review of Immunologic Manifestations of COVID-19 Infection and Vaccination	0
Physical Activity for Human and Planetary Health	0
Ear, Nose, and Throat Manifestations of Vasculitis and Other Systemic Autoimmune Diseases	0
Psoriatic Arthritis Updates	0
Vasculitis Mimics and Other Related Conditions	0
Contributors	0
Foreword	0
Guideline Development and Implementation in Rheumatic Disease	0
Eric Bywaters and Barbara Ansell	0
The Role of Imaging in Diagnosis and Monitoring of Large Vessel Vasculitis	0
Integrative Rheumatology	0
Contributors	0
Systemic Lupus Erythematosus Risk	0
Suppressor of Cytokine Signaling 1 Haploinsufficiency	0
Best Approaches to the Care of Systemic Sclerosis Patients	0
Environmental Exposures of Concern for Rheumatologists	0
Scleroderma Skin	0
Forthcoming Issues	0
Considerations for Coronavirus Disease 2019 Vaccination Among B-Cell-Depleted Patients	0